Screener
Celldex Therapeutics CLDX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's prepaid & other current?
- Celldex Therapeutics (CLDX) reported prepaid & other current of $7.11M in Q2 2026.
- How has Celldex Therapeutics's prepaid & other current changed year-over-year?
- Celldex Therapeutics's prepaid & other current decreased by 60.4% year-over-year, from $17.98M to $7.11M.
- What is the long-term trend for Celldex Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Celldex Therapeutics's prepaid & other current has grown at a 54.1% compound annual growth rate (CAGR), from $1.62M to $14.08M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Celldex Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude